Fair/Congress
Program Highlights
The 18th edition of BIO-Europe Spring (BES) returns to Barcelona from March 18 to 20, 2024. For the fourth time, the city will host the most important conference in Europe for the biotechnology and pharmaceutical industry.
The BioRegion of Catalonia will have an exhibition space (stand 20) to showcase the most important assets of the ecosystem and reaffirm its position as one of the main European health hubs.
Biocat leads the host committee, along with the Government of Catalonia, the Barcelona City Council, and other entities in the ecosystem.
Check out the official program to obtain detailed information about all the activities.
Monday, March 18
10:00 - 10:30 | Opening remarks - Room 112
- Claire Match – Portfolio Director, Europe, EBD Group
- David Thomas – SVP, Industry Research, Biotechnology Innovation Organization (BIO)
- Miquel Rodríguez Planas – Director of Economic Development and Promotion of Barcelona City Council
- Oriol Alcoba – Director of Industry of the Government of Catalonia
12:00 - 12:30 | Cluster Drinks: Aligning agendas with INNAXE and CEBR – Barcelona BioRegion of Catalonia Booth #20
- Montse Daban - Strategic Foresight and International Relations Director BIOCAT
- Anaïs Le Corvec - Managing Director at Council of European BioRegions (CEBR)
14:00 - 14:45 | For a greener globe: biopharma's journey towards a sustainable future - Exhibit Hall Stage
- Jordi Ferrer - Investment Director, Ship2B Ventures
- Mar Guell - Director, Sustainable Business, Kreab
- Jose Maria Fernandez - Partner, Aliath Bioventures
- Jean-Patrick Hennebelle - SVP, Head of Global Late-Stage Partnering, IPSEN
- Joe Hopcraft - Client Partner, Biotech, IQVIA
- Stephane Thiroloix - CEO, AlgoTx
15:00 - 15:45 | Rising leaders in healthcare: pioneers of creativity and innovation – Room 112
- Lucie Ellis- Executive Director In Vivo, Citeline
- Miquel Vila-Perelló- CEO, Splice Bio
- Sandra Von Meier- Head of Business Development&Licensing, Debiopharm International S.A.
- Angeli Moeller- Head of DIGI (Data and Integration Generating Insights), ROCHE
16:00 - 16:45 | Pharma Company Presentation: Almirall - Room 111
16:15 - 17:00 | Paving the path for groundbreaking ATMP’s - Room 111
- Moderator: Robert Fabregat- -CEO - Biocat
- Manel Esteller, Josep Carreras Leukaemia Research Institute
- Lluís Pareras, Invivo Ventures
- Alessandra Magnani, Hospital Sant Joan de Déu
- Toni Andreu, EATRIS
17:30 - 18:30 | Delegation Organizer Reception - Exhibit Hall Stage
19:00 - 21:00 | Evening Reception - MNAC
Tuesday, March 19
09:30 - 09:45 | Pharma Company Presentation – Sanofi - Room 111
- Peter Dolan - Director of Business Development, Out-Licensing, Sanofi
09:45 - 10:30 | Therapeutic Insights. Room 111 - Neuroscience frontier: identifying opportunities of transformative therapies for neurological conditions
Moderator: Mike Ward - Global Head of Thought Leadership, Decision Resources Group, part of Clarivate
- Khatereh Ahmadi - Head of Search and Evaluation Team, MSD
- Anna Rivkin - VP, Business Development, Immunology, Cardiovascular, and Neuroscience, Bristol Myers Squibb
- Clement Gautier - Head of External Innovation Neuroscience & Rare Disease, IPSEN
- Tania Nadal - Clinical Development Director, Ferrer
10:00 - 10:45 | Business of Biotech. In collaboration with YVC Collective - Room 112
In sync or offbeat: are the expectations of VCs and entrepreneurs aligned?
Moderator: Francisca Peixoto - Co-Founder, LifeLink Ventures
Moderator: Joana Correia - Analyst at Aliath Bioventures, Aliath Bioventures
- Jack O’Meara - CEO, Ochre Bio
- Amanda Wagner - CEO, Immunitas Therapeutics
- Thomas Tan - Principal, Sound Bioventures
- Valerie Vanhooren - CEO, Ona Therapeutics
11:00 - 11:45 | Business of Biotech. New generation of life science venture investing- Room 112
Moderator: Karen Chan - Associate, BioGeneration Ventures
- Laura Lane - VP - Venture Sciences (Europe), Eli Lilly & Co
- Clara Campas - Managing Partner and Co-Founder, Asabys
- Jose Mesa - Partner, Columbus Venture Partners
- Tracy Weightman - Associate Director, Intermediate Capital Group (ICG)
14:00 - 14:45 | Startup Stories, how it started, how it is going - Room 112
- Montserrat Vendrell - Partner Aliath Bioventures
- Laura Soucek - CEO Peptomyc
- Marie Eve-Beaulieu - CSO Peptomyc
15:00 - 17:00 | Startup competition - Room 112
- Stephanie Marrus - Managing Director, University of California San Francisco
- Raul Martin - Partner, Ysios Capital
- Hakan Goker - Managing Director, M Ventures
- Oscar Perez - CSO, Ferrer
16:00 - 16:45 | Unleashing healthcare: the power of AI, data, and personalized therapies. Room 111
Moderator : Bjorn Arvidsson - Managing Director, STUNS Life science
- Jessica Shull - Director of Digital Therapeutics, Vicore Pharma AB
- Victor Guallar - ICREA Research Professor, Barcelona Supercomputing Center
- Prabhu Velusami - Senior Director, Early Innovation Partnering (Retina & Data Sciences), Johnson & Johnson Innovation
- Friedrich Von Bohlen - Co-Founder and CEO, Molecular Health GmbH
- Amparo Cuellar - Business Development Director, BioLizard
16:00 - 16:30 | Talent is the new gravity: lessons from Barcelona - Exhibit hall stage
- Koen Vandercaveye- Director of Investment Promotion, Barcelona&Partners
- Valerie Vanhhooren- CEO Ona Therapeutics
- Sonia Velasco- Partner, Cuatrecasas
- Gonzalo Parra- Bioinformatics Researcher. Barcelona Supercomputing Center
- Juan Diego Casas- Global Talent Scout, AstraZeneca
18:00 - 19:00 | Exhibitor Reception with Josep Sanfeliu in the piano – Barcelona BioRegion of Catalonia Booth #20
- Josep Ll. Sanfeliu- Managing Partner, Asabys Partners
Wednesday, March 20
11:00 - 11:45 | Business development round-up “have we got a deal? - key takeaways from this week's partnering meetings”
Moderator: Mike Ward - Global Head of Thought Leadership, Decision Resources Group (Part of Clarivate)
- Carlos Buesa - CEO, Oryzon Genomics
- Claudia Blattner - VP and Business Development, Immatics Biotechnologies GmbH
- Jeremy Benattar - Marketing Strategy Director, Adocia
- Selwin Ho - CEO, Medigene
- Patrick Meyer - Senior Director Global Strategic BD, Rentschler Biopharma SE
16:00 | Closing reception - Barcelona BioRegion of Catalonia Booth #20